Of Mice and Men: NAD+ Boosting with Niacin Provides Hope for Mitochondrial Myopathy Patients

Research output: Contribution to journalArticle

Abstract

In this issue of Cell Metabolism, Pirinen et al. (2020) show that disruption in NAD+ homeostasis is a key component of the pathogenesis of mitochondrial myopathy in humans that can be targeted by the administration of the NAD+ precursor niacin, identifying NAD+ boosting as a potential treatment for this devastating disease.

Original languageEnglish (US)
Pages (from-to)1041-1043
Number of pages3
JournalCell Metabolism
Volume31
Issue number6
DOIs
StatePublished - Jun 2 2020

ASJC Scopus subject areas

  • Physiology
  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'Of Mice and Men: NAD<sup>+</sup> Boosting with Niacin Provides Hope for Mitochondrial Myopathy Patients'. Together they form a unique fingerprint.

  • Cite this